Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128995) titled 'A Phase Study of Sonrotoclax Plus Chemotherapy in Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia' on July 29.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College.
Condition:
pediatric patients with relapsed/refractory Acute Myeloid Leukemia
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-01
Target Sample Size: Sonrotoclax treatment group:20;
Countries of Recruitment:
China
To know more, visit https://www.ch...